Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

Sitagliptin reduces transforming growth factor-β1 and Platelet derived growth factor-BB in regulation of UAER in type 2 diabetic nephropathy stage III patients

Department of Endocrine and Metabolic Disease, the Second Affiliated Hospital of Chongqing Medical University

Biography:

Ke Li is currently working in the Department of Endocrine and Metabolic Disease, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, PR China. One of research work is Simultaneous determination of five isosteroidal alkaloids in siberian fritillary bulb in rat plasma and its application in pharmacokinetic study by HPLC-MS/MS

Subjects of specialization: Sitagliptin, Diabetic nephropathy, Transforming growth factor-?1, Platelet derived growth factor-BB

Research Gate
Get the App